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Abstract 
Background: Historically, plants have proven their value as a source of phytochemicals with therapeutic potentials 
and recently they play an important role in the discovery of novel drugs.
Objectives: The current study aimed to investigate new antiobesity drugs from Plumbago europaea and Plumbago 
auriculata through the inhibition of the adsorption of dietary lipids. In vitro porcine pancreatic lipase inhibitory tests 
were conducted with weight reduction property as well as this study aimed to explore the antioxidant potential and 
to estimate total phenolic, flavonoid, and tannin contents in both of the studied species.
Methods: Antioxidant capacity was evaluated using ferric reducing antioxidant power and DPPH assays, and porcine 
pancreatic lipase inhibitory tests were conducted using the UV spectrophotometric method, while total flavonoid, 
phenol, and tannin contents were estimated using standard phytochemical analytical methods.
Results: Antioxidant potential and total flavonoid, phenol, and tannin contents of P. europaea were significantly 
higher than those of P. auriculata, and both of the studied species have potential antiobesity activity in comparison 
with orlistat.
Conclusion: Results of the present study show that both of the studied Plumbago species consist of bioactive com-
pounds that can act as lipase inhibitors and therefore can be useful for the development of functional foods against 
obesity. It can also be used as a source of lead compounds for designing new antiobesity drugs. Further isolation, 
identification, and characterization of phyto-active compounds responsible for antiobesity action are required to 
evaluate the full therapeutic potentials of these plants.
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Background
For millennia, the plant kingdom has been a valuable 
source of therapeutic agents and till now many modern 
drugs are semi-synthesized or isolated from these natural 
sources [1].
In the past decades, the major focus of pharmaceuti-
cal companies was mainly on synthetic molecules as a 
source of drug discovery due to their effectiveness, ease 
of production, and supply. For all these reasons, synthetic 
medications spread globally, while drug discovery from 
natural sources was associated with some intrinsic dif-
ficulties, and the pharmaceutical industry has shifted its 
main focus to synthetic molecules [2–4]. Unfortunately, 
many side effects and adverse reactions were associated 
with these synthetic drugs, and the world has witnessed 
an increase in the use of plants to treat diseases and to 
promote better health [5, 6].
One of the most important challenges that are still fac-
ing humanity is weight gain and obesity. This problem 
is drawing the attention of both the cosmetic and the 
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pharmaceutical industries. In fact, many countries con-
sider a slim body as a factor of beauty. In addition, obe-
sity is currently considered a worrying epidemic disorder. 
In fact, it touches adults, as well as children and teenag-
ers. It was estimated that about 300,000 people die each 
year from obesity and related causes, which puts this dis-
order as the second leading cause of death. In fact, being 
both overweight and obese increases the risk of several 
diseases and health conditions such as high triglycerides, 
cholesterol, diabetes, heart disease, high blood pressure, 
tumors (breast, colon, and endometrial), sleep disorders, 
and respiratory problems [7–9].
Previous studies showed that some medicinal plants 
contain mixtures of antioxidant phytochemical com-
pounds such as flavonoids, tannins, and polyphenols that 
can inhibit or reduce oxidative deterioration of lipids, pro-
teins, and DNA, consequently preventing neurodegenera-
tive diseases, radiation damage, atherosclerosis, chronic 
inflammatory diseases, carcinogenesis, arthritis, aging, 
liver injury, and other pathological disorders [10–12].
Both of the studied plants species Plumbago europaea 
and Plumbago auriculata (Fig. 1) belonged to the Plum-
baginaceae family. Plumbago europaea L., also known 
as the common leadwort, is a perennial plant which is 
native to the Central Asia and Mediterranean regions. 
The plant is well known to contain europetin flavonol and 
plumbagin naphthoquinones [13–15]. The P. europaea 
plant is used for the treatment of respiratory disorders, 
hepatitis, edema, leprosy, inflammations, scabies, tooth-
ache, warts, blisters, injury, calluses, and skin hardness 
in traditional Palestinian, Jordanian, Italian, and Turkish 
folkloric ethno-medicines [16–22].
Plumbago auriculata Lam. (Cape Leadwort) is a spe-
cies of the perennial flowering plants which are found in 
South Africa, subtropical gardens in Florida, and in all 
the warm winter climate regions across the world [23]. 
In South African and Arabian folk medicines, P. auricu-
lata is used for the treatment of malaria, wounds, gastro-
esophageal reflux disease, broken bones, and to remove 
warts [24–27]. Sitosterol steroids, plumbagin naphtho-
quinones, epi-isoshinanolone, 3-O-glucosylsitosterol, 
palmitic acid, and plumbagic acid were isolated from P. 
auriculata [24].
The current study aimed to investigate new antiobes-
ity drugs from the leaves of P. europaea and P. auriculata 
through the inhibition of the adsorption of dietary lipids. 
In vitro porcine pancreatic lipase inhibitory with weight-
reducing properties were conducted for this purpose. 
In addition, this study aimed to explore the antioxidant 
potential and to estimate total phenolic, flavonoid, and 
tannin contents in both of the studied Plumbago species.
To the best of our knowledge, all the evaluated plants in 
this study have not been screened before, either for their 




Shaker device (Memmert shaking incubator, Germany), 
rotary evaporator (Heidolph OB2000 Heidolph VV2000, 
Germany), UV–visible spectrophotometer (Jenway 7135, 
England), grinder (Moulinex model, Uno, China), and 
balance (Rad wag, AS 220/c/2, Poland) were used in this 
study.
Chemicals and reagents
Methanol (Loba Chemie, India), acetone (Alzahraa, Pal-
estine), Millon’s reagent (Gadot, Israel), ninhydrin solu-
tion (Alfa Agar, England), Benedict’s reagent (Gadot, 
Israel), Molisch’s reagent, H2SO4, iodine solution (Alfa-
Aesar, England), NaOH (Gadot, Israel), chloroform, HCl 
(Sigma-Aldrich, Germany), magnesium ribbon, acetic 
acid (Frutarom Ltd., Israel), FeCl3 (Riedel–de–haen, 
Germany), Folin–Ciocalteu reagent (Sigma-Aldrich, 
Germany), NaHCO3 (Merck, Germany), trichloro-
acetic acid (Sigma-Aldrich, Germany), (s)-(-)-6-hy-
droxy-2,5,7,8–tetramethylchroman-2 carboxylic acid 
(Trolox) (Sigma-Aldrich, Denmark), 2,2-diphenyl-
1-picrylhydrazyl (DPPH) (Sigma-Aldrich, Germany), 
dimethyl sulfoxide (DMSO) (Riedel–de–haen, Ger-
many), acetonitrile (Sigma-Aldrich, Germany), porcine 
pancreatic lipase type II (Sigma, USA), p-nitrophenol 
(PNP) (Sigma-Aldrich, Germany), orlistat, quercetin 
(Sigma, USA), gallic acid, AlCl3, sodium nitrite, vanil-
lin, catechin (Sigma- Aldrich, Germany), and potassium 
ferricyanide (Riedel–de–haen, Germany) were used in 
this study.
Plant materials
The leaves of P. europaea and P. auriculata were col-
lected in June, 2015 from the Jericho and Tubas regions 
of Palestine. Botanical identification was carried out in 
the Pharmacognosy and Herbal Products Laboratory at 
An-Najah National University by the Pharmacognosist 
Dr. Nidal Jaradat, and the voucher specimen codes were 
Pharm-PCT-1899 and Pharm-PCT-1900, respectively.
The leaves were washed and then dried in the shade at 
room temperature until all the plant parts became well 
dried. After drying, the plant materials were ground well 
into a fine powder using a mechanical blender and trans-
ferred into airtight containers with proper labeling for 
future use.
Preparation of different extracts of plants
About 10 g of the grounded leaves of P. europaea and P. 
auriculata plants were soaked separately in 1  l of three 
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different solvents (water, methanol, and acetone), and 
each of the extracts was placed in a shaker device at 100 
rounds per minute for 72  h at room temperature and 
then stored in a refrigerator for 4  days. After that, the 
extract was filtered using Whatman filter paper No. 1 and 
concentrated under vacuum on a rotary evaporator at 
35 °C. The crude extracts were then stored at 4 °C in the 
refrigerator for further use [28].
Qualitative phytochemical analysis
Qualitative preliminary phytochemical screening of 
primary and secondary metabolic compounds such as 
starch, phenols, cardiac glycosides, flavonoids, saponin 
glycosides, alkaloids, steroids, volatile oils, and tannins 
was carried out according to the standard common phy-




Methanolic extracts were subjected to this assay by 
preparing methanolic solutions of different concentra-
tions (100, 200, 300, 400, and 500 µg/ml), and 1 ml from 
each dilution was mixed with 2.5 ml of phosphate buffer 
(200 mM, pH 6.6) and 2.5 ml of 1% potassium ferricya-
nide in a separate tube.
The tubes were placed in a boiling water bath for 
20  min at 50  °C, cooled rapidly, and then mixed with 
2.5 ml of 10% trichloroacetic acid and 0.5 ml of 0.1% fer-
ric chloride. The amount of iron (II)–ferricyanide com-
plex formed was determined by measuring the formation 
of Perl’s Prussian blue at 700  nm after 10  min, and the 
presence of antioxidants (reductants) in the sample 
would result in the reduction of Fe3+ to Fe2+ by donat-
ing an electron. The amount of Fe2+ complex formed by 
the reduction of Fe3+ can be monitored by measuring 
the formation of color complex at 700  nm. An increase 
in absorbance indicates an increase in reduction ability. 
The reducing capacity of the compound may serve as a 
significant indicator of its potential antioxidant activity. 
This would have the effect of converting free radicals to 
more stable products and thus terminating free radical-
initiated chain reactions [31].
DPPH assay
A stock solution of a concentration of 1 mg/ml in metha-
nol was firstly prepared for the plant extract and Trolox. 
The working solutions of different concentrations (1, 2, 3, 
5, 7, 10, 20, 30, 40, 50, 80, and 100 μg/ml) were prepared 
by serial dilution of the stock solution with methanol. 
DPPH was freshly prepared at a concentration of 0.002% 
w/v. The DPPH solution was mixed with methanol and 
the above-prepared working concentration in a ratio of 
1:1:1, respectively. The spectrophotometer was zeroed 
using methanol as a blank solution. The first solution of 
the series concentration was DPPH with methanol only. 
The solutions were incubated in the dark for 30  min at 
room temperature before the absorbance readings were 
recorded at 517  nm [32]. The percentage of antioxidant 
activity of the plants and the Trolox standard were calcu-
lated using the following formula:
where A is the optical density of the blank and B is the 
optical density of the sample.
The antioxidant half maximal inhibitory concentra-
tion (IC50) for the plant samples and the standard were 
calculated using BioDataFit edition 1.02 (data fit for 
biologist).
Pancreatic lipase inhibition
Preparation of lipase stock solution and plant extract  
dilution series
The porcine pancreatic lipase inhibitory assay was 
adapted from Zheng et  al. [33] and Bustanji et  al. [34] 
with some modifications. From the prepared 1  mg/ml 
plant extract stock solution in 10% DMSO, solutions 
of five different concentrations (200, 400, 600, 800, and 
1000  μg/ml) were prepared, while 1  mg/ml stock solu-
tion of pancreatic lipase enzyme was prepared imme-
diately before use, which was suspended in Tris–HCl 
buffer.
Preparation of lipase substrate stock solution
The stock solution of PNPB (p-nitrophenyl butyrate) 
was prepared by dissolving 20.9 mg of PNPB in 2 ml of 
acetonitrile. For each working test tube, 0.1 ml of por-
cine pancreatic lipase (1  mg/ml) was added to a test 
tube containing 0.2 ml plant extract from each diluted 
solution series for each studied plant. The resulting 
mixture was then made up to 1  ml by adding Tris–
HCL solution and incubated at 37 °C for 15 min. After 
the incubation period, 0.1  ml of PNPB (p-nitrophenyl 
butyrate) solution was added to each test tube. The 
mixture was again incubated for 30 min at 37  °C. Pan-
creatic lipase activity was determined by measuring 
the hydrolysis of p-nitrophenolate to p-nitrophenol at 
405  nm using a spectrophotometer. The same proce-
dure was repeated for Orlistat which was used as a ref-
erence compound [35].
Determination of total tannin content in the different 
extracts
Total tannin content (proanthocyanidins) was deter-
mined according to the method of Sun et  al. [36], with 
Percentage of inhibition of DPPH activity (%)
= (A− B)/A× 100%,
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some modification. To 0.5 ml of each of the diluted cat-
echin solutions of different concentrations (0.1, 0.4, 0.5, 
0.7, and 1 mg/ml), 3 ml of 4% vanillin solution in meth-
anol and 1.5  ml of concentrated HCl were added. The 
mixture was allowed to stand for 15  min, and absorp-
tion was measured at 500  nm against methanol as a 
blank. The amount of total tannins is expressed as mg 
(+)-catechin/g  plant extract (mg CAE/g). All samples 
were analyzed in triplicate. The same procedure was 
repeated for methanolic extracts of the two plants [36].
Determination of total phenolic content
Total phenolic content in the plant methanolic extract 
was determined using spectrophotometric method with 
some modifications [37]. 1  mg/ml stock aqueous solu-
tions of methanolic extracts were prepared. The reaction 
mixture was prepared by mixing 0.5 ml of plant extract 
solution, 2.5 ml of 10% Folin–Ciocalteu reagent dissolved 
in water, and 2.5  ml of 7.5% of NaHCO3 aqueous solu-
tion. The samples were incubated in a thermostat at 45 °C 
for 45 min. The absorbance was determined using a spec-
trophotometer at the wavelength of 765 nm. The samples 
were prepared in triplicate for each analysis and the mean 
value of absorbance was calculated. The same procedure 
was repeated for the standard solution of gallic acid and 
the calibration line was construed. Based on the meas-
ured absorbance, the concentration was expressed in 
terms of gallic acid equivalent (mg of GAE/g of extract), 
and this procedure was repeated three times for both of 
the studied Plumbago species.
Determination of total flavonoid content
Total flavonoid content was measured with the aluminum 
chloride colorimetric assay [38]. 10 mg of quercetin was 
dissolved in 100 ml of methanol and then diluted to 10, 
30, 50, 70, and 100 µg/ml using methanol. The stock solu-
tion of plant extract was prepared by dissolving 100 mg of 
the methanolic extract in 5 ml methanol and transferred 
to a 10-ml volumetric flask and made up to the volume 
with methanol. 0.3 ml of 5% sodium nitrite solution was 
added into each working test tube. After 5 min, 0.3 ml of 
10% aluminum chloride was added. At the 6th minute, 
2 ml of 1 M sodium hydroxide was added. Finally, the vol-
ume was made up to 10 ml with distilled water and mixed 
well. The absorbance was measured at 510  nm using a 
UV–visible spectrophotometer. A blank test was per-
formed using distilled water. Quercetin was used as the 
standard. The samples were analyzed in triplicate. The 
calibration curve was plotted using standard quercetin. 
The total flavonoid content of the extract was expressed 
as mg of quercetin equivalents/g (mg of QUE/g) of plant 
extract, and this procedure was repeated three times for 
both of the studied plants species.
Results
Phytochemical screening
Qualitative phytochemical screening examinations of P. 
europaea and P. auriculata showed that the aqueous and 
organic (acetone, methanolic) extracts contain the same 
phytochemical classes such as cardiac glycosides, alka-
loids, starch, phenols, tannins, phytosteroids, flavonoids, 
and volatile oils as presented in Table 1.
Total tannin content
A standard calibration curve (Fig.  2)  was established to 
calculate the percentage of tannins in the methanolic 
extracts of P. europaea and P. auriculata, using the fol-
lowing equation:
where Y is the absorbance at 500 nm and X is the total 
tannin content in the plant methanolic extract.
The total tannin content according to the standard cali-
bration curve equation shown in Fig. 1 was 29.58 ± 0.24 mg 
CAE/g for P. europaea methanolic extract, while that for P. 
auriculata was 9.55 ± 0.2 mg CAE/g (Fig. 2).
Total phenolic content
Estimation of total phenolic content was carried out 
according to the standard calibration curve  (Fig.  3) and 
the results were expressed as mg/g gallic acid equivalent 
using the standard calibration curve equation: 
where Y is the absorbance at 765 nm and X is the total 
phenolic content in the plant extract.
The total phenolic content in P. europaea methanolic 
extract was 41.5  ±  0.58  mg GAE/g of plant extract, 
which is a relatively high percentage of phenolic con-
tent, while in P. auriculata the total phenolic content 
was 24.3 ±  0.45  mg GAE/g plant extract which is rela-
tively low in comparison with the methanolic extract of 
P. europaea.
Total flavonoid content
A standard calibration curve was prepared to calculate 
the percentage of flavonoid content using the following 
equation:
where Y is the absorbance at 410 nm and X is the total 
flavonoid content in the plant methanolic extract, as pre-
sented in Fig. 4.
From the standard calibration curve shown in Fig.  3, 
the total flavonoid content in the methanolic extract of 
P. europaea was 94.66 ± 0.94 mg QUE/g of plant extract 
which is considered a relatively high percentage of 
Y = 0.9554X + 0.0003, R2 = 0.9988,
Y = 7.515X + 0.0308, R2 = 0.9927,
Y = 0.0003X + 0.00016, R2 = 0.9966,
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flavonoid content. On the other hand, the total flavonoid 
content in the methanolic extract of P. auriculata was 
87.12 ± 0.5 mg QUE/g of plant extract.
All the previous results of total phenolic, flavonoid, and 
tannin contents of methanolic extract for both Plum-
bago plant species are listed and explained in Table 2 and 
Fig. 5. 
Antioxidant screening assay
IC50 values for P. europaea and P. auriculata were 21.38 
and 89.12 µg/ml, respectively, while that for Trolox was 
1.85 µg/ml  (Fig. 6). This indicates the high potential for 
free radical scavenging of P. europaea versus P. auricu-
lata. The antioxidant can donate an electron to free 
radicals, which leads to neutralization of the radicals. 
Fig. 1 The studied Plumbago plant species, where a represents Plumbago europaea and b represents Plumbago auriculata
Table 1 Phytochemical classes identified in  the aqueous, acetone, and  methanolic extracts of  both plumbago studied 
species
(−) means the absence of the content, (+) means low content, (++) means mild content, and (+++) means high content
Phytochemical classes Aqueous extract Methanolic extract Acetone extract
P. europaea P. auriculata P. europaea P. auriculata P. europaea P. auriculata
Cardiac glycosides ++ + ++ + +++ ++
Saponin glycosides − − − − − −
Alkaloids − − − − − −
Starch +++ ++ − − − −
Phenols ++ + ++ + ++ +
Volatile oil + + + + + +
Tannin + + ++ + ++ +
Phytosteroids ++ + +++ ++ +++ ++
Flavonoids ++ + +++ ++ +++ ++
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Reducing power was measured by direct electron dona-
tion in the reduction of Fe3+(CN−)6–Fe2+(CN−)6 (Fig. 7). 
The product was visualized by forming the intense Prus-
sian blue color complex and then the absorbance was 
measured at the λ value of 700 nm. As shown in Fig. 6, 
a higher absorbance value indicates a stronger reducing 
power of the samples.
Using ferric reducing power assay, IC50 value for 
the methanolic extract of P. europaea was 69.18  µg/
ml and that for the methanolic extract of P. auriculata 
was 70.79 µg/ml, whereas the IC50 value for Trolox was 
50.12 µg/ml. This result indicates the relatively high ferric 
reducing activity of these two extracts compared to pure 
standard Trolox.
Pancreatic lipase enzyme inhibition activity
The methanol extracts anti-lipase IC50 value of P. euro-
paea and P. auriculata was 134.29 and 130.32  µg/ml, 
respectively, as shown in Fig. 8. This result showed that 
both the studied Plumbago species possess relatively the 
same inhibitory action against lipase enzyme.
The orlistat reference standard compound showed a 
very high percentage of inhibition against pancreatic 
lipase enzyme with an IC50 value of 29.9 µg/ml, while the 
extracts of P. europaea and P. auriculata showed rela-
tively moderate lipase inhibition compared with orlistat 
(Fig. 8).
Discussion
Recently, the focus on medicinal plants research has 
increased considerably, especially for those plants that 
were used in folk medicines. This increasing interest 
is due to the scarcity of therapeutic agents available to 
treat chronic diseases, increasing of bacterial resist-
ance and the harmful side effects of chemical com-
pounds [39, 40]. Natural plant products containing 
polyphenolic compounds such as phenolic acids, tan-
nins, anthocyanins, and flavonoids were demonstrated 
to have potential health benefits for the treatment of 
metabolic disorders such as diabetes mellitus, hyper-
cholesterolemia, overweight, and obesity [41]. Several 
studies were conducted on natural products in order 
to assess their pharmacological activities including 
antioxidant and anti-lipase effects [42–44].
Therefore, the consumption of flavonoids in food and 
other supplements has been advised to reduce weight 
gain and obesity [45–47].
In this context, P. europaea and P. auriculata exhibited 
high flavonoid contents of 94.66 mg QUE/g and 87.12 mg 
QUE/g, respectively, which may explain their anti-lipase 
activity.
In addition, P. europaea and P. auriculata showed a 
promising antioxidant activity in both of the utilized 
DPPH and ferric reducing assays.
On the other hand, total phenolic content was higher 
in P. europaea, which was 41.5  mg GAE/g, while in 
Fig. 2 Standard calibration curve for catechin measured at 500 nm 
wavelength
Fig. 3 Standard calibration curve for gallic acid measured at 765 nm 
wavelength
Table 2 Total phenolic, flavonoid, and tannin contents of methanolic extracts for P. auriculata and P. europaea
Studied species of Plumbago 
plants
Total phenolic content (mg 
GAE/g) ± SD
Total flavonoid content (mg 
QUE/g) ± SD
Total Tannin content 
(mg CAE/g) ± SD
P. auriculata 24.3 ± 0.22 87.12 ± 0.15 9.55 ± 0.80
P. europaea 41.5 ± 0.20 94.66 ± 0.08 29.58 ± 0.20
Page 7 of 9Jaradat et al. Chem. Biol. Technol. Agric.  (2016) 3:31 
P. auriculata the total phenolic content was 24.3  mg 
GAE/g. At the same time, the total tannin content was 
also higher in P. europaea than in P. auriculata, which 
were 29.58 mg CAE/g and 9.55 mg CAE/g, respectively.
In another investigation conducted by Amoo et al. [48] 
in South Africa, the total phenolic and flavonoid contents 
in P. auriculata were 15.0 mg GAE/g and 5.5 mg QUE/g, 
respectively. This means that wild-growing P. auriculata 
used in our study had much better total phenolic and fla-
vonoid contents than South African P. auriculata [48].
Using ferric reducing power assay, the IC50 values were 
69.18 and 70.79  µg/ml for the methanolic extracts of P. 
europaea and P. auriculata, respectively, whereas the 
IC50 value for Trolox was 50.12  µg/ml. This result indi-
cates the relatively high ferric reducing activity of these 
two extracts compared to Trolox.
Moreover, using DPPH assay the IC50 values for P. 
europaea and P. auriculata were 21.38 and 89.12 µg/ml, 
respectively, while the IC50 value for Trolox was 1.85 µg/
ml. This indicates the high potential antioxidant activity 
of P. europaea versus P. auriculata.
Moreover, there was a significant linear correlation 
between the antioxidant activity determined using the 
Fig. 4 Standard calibration curve for quercetin measured at 410 nm 
wavelength
Fig. 5 Total phenolic content (TPC), total flavonoid content (TFC), 
and total tannin content (TTC) of the methanolic extracts of P. auricu-
lata and P. europaea plants
Fig. 6 DPPH free radical scavenging curve for the methanolic 
extracts of P. europaea and P. auriculata and Trolox
Fig. 7 Ferric reducing power assay using the methanolic extracts of 
P. europaea and P. auriculata and Trolox
Fig. 8 Pancreatic lipase inhibition activity of the methanolic extracts 
of P. europaea and P. auriculata in comparison with orlistat
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DPPH and ferric reducing assays and the total phenolic, 
tannin, and flavonoid contents in both of the studied 
Plumbago species. However, no significant relationship 
was observed between the antioxidant activity and the 
total tannin, phenolic, and flavonoid contents in both of 
the studied Plumbago species and the anti-lipase activity 
because both of the studied species had almost the same 
potential as anti-lipase drugs.
A study conducted by Bircan and Kirbag [49] evalu-
ated the antioxidant activity of P. europaea growing in 
Turkey using DPPH assay and found that it was 83.62 µg/
ml, while in the studied P. europaea growing in Palestine 
it was 21.38 µg/ml which exhibited an antioxidant activ-
ity four times better than that of the Turkish P. europaea 
[49]. In fact, the impact of the flavonoid content on anti-
aging and anti-lipase activities was documented.
On the other hand, both of the studied species had 
more powerful antioxidant activity than Plumbago zey-
lanica that had an antioxidant activity of 88.45  µg/ml 
which was studied by Sini et al. [50] and which is almost 
equal to the antioxidant activity of P. auriculata which 
was 89.12 µg/ml.
In fact, overweight and obesity have become epidem-
ics and are increasing at an alarming rate in both the 
developed and developing countries [51, 52]. Pancreatic 
lipase is considered the principal lipolytic enzyme which 
plays an essential role in the efficient digestion of lipids 
and is responsible for the hydrolysis of about 70% of total 
ingested fats [53].
The IC50 value showed potent inhibitory action against 
lipase enzyme when comparing with Arum palaestinum 
which was previously reported by Bustanji et  al. [54] to 
have potent lipase inhibitory action with an IC50 value of 
107.7 µg/ml.
For the studied Plumbago plant species, the potential 
activity against pancreatic lipase enzyme can be attrib-
uted to the high content of flavonoids which are well 
known to exhibit potential activity against pancreas and 
liver enzymes.
Conclusion
In the present study, the total contents of phytochemical 
compounds including flavonoids, phenols, and tannins as 
well as their antioxidant and antiobesity activities of the 
two species, P. europaea and P. auriculata, were evaluated 
and compared. The obtained results suggested that these 
plants have moderate to potent antioxidant activity and 
both of them had high contents of flavonoids. In addition, 
they could be used as a source of lead drugs for develop-
ing new antiobesity agents. However, further isolation, 
identification, and characterization of phyto-active com-
pounds responsible for anti-lipase action are required to 
evaluate the full therapeutic potentials of these plants.
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